11ukM

London Quick Take – 16 May - FTSE Rises with Bond Yields in Retreat

Neil Wilson
Neil Wilson

Investor Content Strategist

FTSE Rises with Bond Yields in Retreat on Soft US Data


Key Points

  • FTSE 100 rises for second day to close in on 8,700

  • US data weaker, bond yields retreat

  • S&P 500 up for fourth session, tech weighed down by Meta and Amazon

  • UnitedHealth tumbles again

This content is marketing material. This article is not investment advice, capital is at risk.

Big picture: Bond yields matter

Treasury yields have pulled back sharply on some soft US numbers, now Japan is slowing. This is dragging yields down across the space. US PPI and Retail sales data indicates both consumers and business buying time in April and hoping the trade war would resolve itself...so can we read much into the data? The main thing now is what happens to bond yields from here. Look also to big changes in the way foreign holders of US Treasuries are taxed, and rules governing US banks’ Treasury holdings...repatriation of dollars...all part of the trade reset. Basically, the US Treasury department is laying the groundwork for countering any yield surge due to foreign selling. A big question for investors is whether the administration goes after equity income as well as bond income.

Alchemy – scientists at CERN in Switzerland have used the Large Hadron Collider to turn lead into gold...is it over? Spot gold has recovered the $3,200 support after touching $3,120 with the 50-DMA holding.

UK

The FTSE 100 is looking a bit livelier after Thursday’s rally, posting modest gains early Friday. The blue chips snapped a two-day losing streak yesterday and bulls are trying to get over the 8,685 near-term top in order to push on to 8,750. However it does rather look that after a big rally off the early April lows we are now in a phase of consolidation for the index.

St James Place and JD Sports led the index higher, while GSK and AstraZeneca were among the leading large-cap weightings to push the index up.

Investors punished Future heavily for cutting its revenue forecast after a dip in March ad sales hurt its Q1 performance. GoCompare got hit by a decline in car insurance pricing...which was evident yesterday with Admiral down sharpish. First-half sales fell 3% to £378.4 million, with adjusted profit down 5%. Given the Q1 softness and macro backdrop it now expects a low single-digit decline in FY 2025 organic revenue. Shares fell 9% at the open.

Land Securities fell 2% despite a 5% rise in rental income in the quarter. Plans to shift £3 billion out of offices and into retail and residential by 2030.

 

US

 

US PPI collapse – companies ate tariff increases, didn’t pass on to consumers...sign that maybe we don’t get the inflation impulse? The producer price index fell 0.5% after no change in March, contrary to a predicted 0.2% rise. Excluding food and energy, the core PPI declined 0.4%, the steepest since 2015.

US retail sales growth slowed dramatically after the March boost from front-running tariffs. Sales rose 0.1% in April, following the 1.7% surge in spending in March.

US factory production dropped 0.4% in April, the first decline in six months, due to higher import duties and other challenges

Fed Chair Powell warned of high long-term rates and inflation volatility from supply shocks, stressing anchored expectations for growth and reaffirming the Fed's 2% inflation target to prevent job losses.

Meanwhile, Japan's economy shrank by 0.7% annually in the first quarter, its first decline in a year, due to lower exports, higher imports, and stagnant consumer spending.

It was a mixed day for US equities on Thursday. The S&P 500 rose 0.41%, boosted by utilities and consumer staples, while tech struggled with the Nasdaq slightly down amid Amazon and Meta losses. The Dow added 0.65%, driven by GE's 2.8% gain as Qatar selected its engines for Boeing aircraft., while UnitedHealth continued its collapse. The S&P 500 has notched 4 straight days in the green this week, up 4.54% so far this week. It’s looking a tad near-term overbought and we have a $1.2tn in notional SPX options expiring today with the max pain point at 5,840 – wouldn't be surprised to see some pullback from the 5,900 area today.

Shares of Meta fell 2.5% after news that the company is postponing the launch of its highly anticipated AI model, Behemoth.

UnitedHealth just keeps falling – falling knife but going to offer value, seen some clients averaging in. RBC Capital, JPMorgan, Bernstein, Oppenheimer, Morningstar analysts all reiterated overweight – presume they know what is going on?

Alibaba was sharply off on profits miss but growth looks resilient and AI strong. Walmart down after saying it will pass on tariff cost increases to consumers – who are already under a lot of pressure. “The magnitude and speed at which these prices are coming to us is somewhat unprecedented in history,” said CFO John David Rainey. UoM survey data on inflation expectations and consumer sentiment coming but is now totally out of date as it will likely capture peak tariff fear.

Coinbase fell –7% on hack report.

Raytheon - House Representative Josh Gottheimer filed a purchase of Raytheon stock, Gottheimer sits on the House Intelligence Committee. This is the first time he’s bought Raytheon.

Finally, Buffett’s latest 13F for Berkshire Hathaway is out – trims financials, exiting Citigroup position entirely, selling 7% of Bank of America stake, while more than doubling  stake in Constellation Brands and Pool Corp. In the quarter Berkshire made no changes to its Apple stake.

 

Enjoy this article?

Refer a friend and earn £500 commission credits
Refer a friend to Investor                Refer a friend to TraderGO

Introduce a friend to Saxo, and you'll both receive commission credits for future trades

 



Quarterly Outlook

01 /

  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992